---
document_datetime: 2023-10-31 11:11:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/abiraterone-accord-epar-all-authorised-presentations_en.pdf
document_name: abiraterone-accord-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9142219
conversion_datetime: 2025-12-19 23:18:26.048316
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU (MA) Number   | (Invented) name    | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging    | Pack size                   |
|------------------|--------------------|------------|-----------------------|---------------------------|------------------------|-----------------------------|
| EU/1/20/1512/001 | Abiraterone Accord | 250 mg     | Tablet                | Oral use                  | Bottle (HDPE)          | 120 tablets                 |
| EU/1/20/1512/002 | Abiraterone Accord | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Alu) | 56 x 1 tablets (unit dose)  |
| EU/1/20/1512/003 | Abiraterone Accord | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Alu) | 60 x 1 tablets (unit dose)  |
| EU/1/20/1512/004 | Abiraterone Accord | 500 mg     | Film-coated tablet    | Oral use                  | Blister (PVC/PVDC/Alu) | 112 x 1 tablets (unit dose) |